Top insider buys: Apr 10 – Apr 16, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Apr 10 – Apr 16, 2023.

Week 15, 2023

#	Company	Who bought	Shares	Value	Source
1	BTTX Better Therapeutics, Inc.	4 officers/directors Cluster buy David P. Perry, Frank Karbe, Geoffrey M. Parker, Andrew J. Armanino	5,818,181	$4.8M	SEC filings
2	JSPR Jasper Therapeutics, Inc.	10% Owner Qiming U.S. Healthcare Fund II, L.P.	2,666,666	$4.0M	SEC filings
3	PDO PIMCO Dynamic Income Opportunities Fund	Insider Emmanuel Roman	100,000	$1.3M	SEC filings
4	ALOT AstroNova, Inc.	Director Alexis P. Michas	66,952	$967K	SEC filings
5	DMAC DiaMedica Therapeutics Inc.	Chief Business Officer David J. Wambeke	468,750	$750K	SEC filings
6	RMBL RumbleOn, Inc.	10% Owner Stone House Capital Management, LLC	50,000	$411K	SEC filings
7	FGBI First Guaranty Bancshares, Inc.	Director Edgar R. Smith III	17,109	$400K	SEC filings
8	SSOK Sunstock, Inc.	CEO Jason Chang	72,504	$381K	SEC filings
9	BSTG Biostage, Inc.	10% Owner DST Capital LLC	62,500	$375K	SEC filings
10	SMPL Simply Good Foods Co	President and COO Geoff E. Tanner	6,912	$250K	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.